Show simple item record

dc.contributor.authorArmahizer, Michael J
dc.contributor.authorBadjatia, Neeraj
dc.date.accessioned2021-06-07T15:38:47Z
dc.date.available2021-06-07T15:38:47Z
dc.date.issued2021-05-10
dc.identifier.urihttp://hdl.handle.net/10713/15931
dc.description.urihttps://doi.org/10.1161/STROKEAHA.120.031825en_US
dc.language.isoenen_US
dc.publisherLippincott Williams and Wilkinsen_US
dc.relation.ispartofStrokeen_US
dc.subjecteditorialsen_US
dc.subjectanticoagulanten_US
dc.subjectatrial fibrillationen_US
dc.subjectembolismen_US
dc.subjectintracranial hemorrhageen_US
dc.titleEvidence for Andexanet Alpha in Reversing Intracerebral Hemorrhage due to Factor Xa Inhibitors?en_US
dc.typeArticleen_US
dc.identifier.doi10.1161/STROKEAHA.120.031825
dc.identifier.pmid33966496
dc.source.volume52
dc.source.issue6
dc.source.beginpage2106
dc.source.endpage2108
dc.source.countryUnited States


This item appears in the following Collection(s)

Show simple item record